October 14, 2019
Femtogenix Presents Efficacy and Toxicity Data on Antibody Drug Conjugates Containing New Generation of DNA-binding Therapeutic Payloads
Femtogenix presented data from testing Pyridinobenzodiazepine at World ADC 2019, San Diego, in USA, showing its superior efficacy and cytotoxicity of Femtogenix’s sequence-selective DNA-interactive payload molecules toward tumour cells.